Table 3.
Correlates of positive RNA among people who inject drugs, n=150
| Overall | HCV RNA + | HCV RNA- | Unadj.OR(95%CI) | p value | Adj.OR(95%CI) | p value | |
|---|---|---|---|---|---|---|---|
| N (%) | 150(100.0) | 79(52.7) | 71(47.3) | ||||
| Gender | |||||||
| Female | 17 (11.3) | 5 (6.3) | 12 (16.9) | ref | ref | ||
| Male | 133 (88.7) | 74 (93.7) | 59 (83.1) | 3.01 (1.004–9.02) | 0.049 | 0.73 (0.18–2.92) | 0.657 |
| Age (mean, sd) | 43.1 (10.5) | 45.8 (9.9) | 40.1 (10.4) | 0.001 | |||
| 23–35 | 37 (24.7) | 13(16.5) | 24 (33.8) | ref | ref | ref | ref |
| 36–45 | 59 (39.3) | 27(34.2) | 32 (45.1) | 1.59 (0.67–3.63) | 0.305 | 0.65(0.20–2.13) | 0.480 |
| 45–68 | 54 (36.0) | 39 (49.4) | 15 (21.1) | 1.69 (1.25–2.28) | 0.001 | 1.29(0.82–2.01) | 0.272 |
| Race | |||||||
| White | 19 (12.7) | 5 (6.3) | 14 (19.7) | ref | ref | ref | ref |
| Black | 11 (7.3) | 9 (11.4) | 2 (2.8) | 12.60 (2.00–79.44) | 0.007 | 16.12 (1.69–153.73) | 0.016 |
| American Indian | 12 (8.0) | 5 (6.3) | 7 (9.9) | 2.00 (0.43–9.29) | 0.376 | 1.11 (0.19–6.55) | 0.906 |
| Mixed race | 108 (72.0) | 60 (75.9) | 48 (67.6) | 3.50 (1.18–7-10.40) | 0.024 | 2.25 (0.63–8.00) | 0.211 |
| Unhoused, lifetime | |||||||
| No | 38 (25.3) | 25 (31.6) | 13 (18.3) | ref | ref | ||
| Yes | 112 (74.7) | 54 (68.4) | 58 (81.7) | 0.48(0.23–1.04) | 0.063 | ||
| Incarceration | |||||||
| None | 22 (14.7) | 4 (5.1) | 18 (25.4) | ref | ref | ref | ref |
| 1 to 2 | 61 (40.7) | 30 (38.0) | 31 (43.7) | 4.35 (1.32–14.37) | 0.016 | 8.40 (1.82–38.69) | 0.006 |
| 3 or more | 67 (44.7) | 45 (57.0) | 22 (31.0) | 9.20 (2.78–30.48) | <.001 | 15.13 (3.20–71.64) | <.001 |
| Common Substance Use, lifetime | |||||||
| Crack | |||||||
| No | 41 (27.3) | 22 (27.8) | 19 (26.8) | ref | ref | ||
| Yes | 109 (72.7) | 57 (72.2) | 52 (73.2) | 0.95 (0.46–1.94) | 0.947 | ||
| Synthetic | |||||||
| Cannabinoids(i.e, K2) | |||||||
| No | 82 (54.7) | 46 (58.2) | 36 (50.7) | ref | ref | ||
| Yes | 68 (45.3) | 33 (41.8) | 35 (49.3) | 0.74(0.39–1.41) | 0.356 | ||
| Speedball | |||||||
| No | 18 (12.0) | 9 (11.4) | 9 (12.7) | ref | ref | ||
| Yes | 132 (88.0) | 70 (88.6) | 62 (87.3%) | 1.13(0.42–3.02) | 0.809 | ||
| Heroin | |||||||
| No | 30 (20.0) | 17 (21.5) | 13 (18.3) | ref | ref | ||
| Yes | 120 (80.0) | 62 (78.5) | 58 (81.7) | 0.82(0.37–1.83) | 0.624 | ||
| Fentanyl | |||||||
| No | 34 (22.7) | 20 (25.3) | 14 (19.7) | ref | ref | ||
| Yes | 116 (77.3) | 59 (74.7) | 57 (80.3) | 0.72(0.33–1.57) | 0.415 | ||
| Xylazine | |||||||
| No | 79 (52.7) | 40 (50.6) | 39 (54.9) | ref | ref | ||
| Yes | 71 (47.3) | 39 (49.4) | 32 (45.1) | 1.19(0.62–2.26) | 0.599 | ||
| Years of injection(mean, sd) | 17.8 (12.4) | 22.4 (12.0) | 12.7 (10.7) | <.001 | |||
| <=10 years | 56 (37.3) | 17 (21.5) | 39 (54.9) | ref | ref | ref | ref |
| 11–20 years | 29 (19.3) | 15 (19.0) | 14 (19.7) | 2.46 (0.98–6.20) | 0.057 | 2.31(0.72–7.38) | 0.158 |
| 21+ years | 65 (43.3) | 47 (59.5) | 18 (25.4%) | 5.99(2.73–13.16) | <.001 | 4.29 (1.31–14.06) | 0.016 |
| Receptive syringe sharing, last 12months | |||||||
| No | 105 (70.0) | 51 (64.6) | 54 (76.1) | ref | ref | ||
| Yes | 45 (30.0) | 28 (35.4) | 17 (23.9) | 1.74 (0.85–3.56) | 0.127 | ||
| Injected other PWID | |||||||
| 0 | 74 (50.) | 35 (44.9) | 39 (55.7) | ref | ref | ref | ref |
| 1–10 | 43 (29.1) | 19 (24.4) | 24 (34.3) | 0.88 (0.41–1.87) | 0.738 | 0.78 (0.31–1.98) | 0.599 |
| 11 or more | 31 (20.9) | 24 (30.8) | 7 (10.0) | 3.81 (1.47–9.90) | 0.006 | 5.47(1.70–17.60) | 0.004 |